A wannan makon, John Ioannidis da abokan aikinsa wallafa wata takarda a kan Covid-19 bayar da shawarar son zuciya a cikin BMJ, Ƙarshe cewa 'BMJ yana da tsattsauran ra'ayi don goyon bayan marubutan da ke ba da shawara ga wata hanya mai tsanani don ragewa COVID-19.'
Marubutan ba su ja da baya ba, suna masu cewa 'BMJ na da babban ra'ayi ga takamaiman shawarwarin da ke da alaƙa da COVID-19 wanda ke ba da fifiko ga matakan tashin hankali'. BMJ ta zama hanyar fita don masu ba da shawara na indieSAGE/Vacines-Plus waɗanda suka fi ƙarfin membobin SAGE, (Ninka 16), Babban Sanarwar Barrington (GBD) masu ba da shawara (nnki 64), da ninki 16 idan aka kwatanta da mafi yawan rukunin da aka ambata. Gajerun ra'ayi da nazari sun kori yawancin waɗannan bambance-bambance.
Masu ba da shawara na ƙuntatawa, matakan mayar da hankali sun kusan bace daga cikin BMJ Shafukan: 'Masu gyara BMJ, ma'aikata da masu ba da shawara ga masu ba da gudummawa sun haɓaka ɗimbin ɗimbin wallafe-wallafe, wanda ya ƙunshi yawancin ra'ayoyin da a gaba ɗaya (kamar yadda BMJ ta yarda) ba a yi bitar waje ba a cikin BMJ.'
idan BMJ ya kasance mai watsa shirye-shirye, da an kai rahoto ga OFCOM: mai kula da harkokin sadarwa na Burtaniya saboda ya kamata a ba da labarin ba tare da nuna son kai ba.
Hanyar BMJ shine ainihin akasin martanin da suka bayar game da Cutar Murar Alade. A lokacin, sun shiga ƙungiyar Tamiflu don buga namu reviews.
Sun kuma kirkiro da Yakin Tamiflu: Kamfen ɗin buɗaɗɗen bayanai na farko na BMJ ya yi niyya don matsawa kamfanoni lamba don fitar da bayanan gwaji na asibiti na magunguna biyu na rigakafin mura a duniya, Tamiflu da Relenza. Tare da Deb Cohen a matsayin editan binciken su, sun taimaka waƙa da bayanan.
A farkon barkewar cutar, da BMJ ya kasance akan irin wannan waƙa: A ranar 2 ga Maris 2020, Tom wallafa Covid-19—Tambayoyi da yawa, babu cikakkun amsoshi a cikin BMJ Ra'ayi. "Masu barkwanci da masu fashin baki suna yin karin lokaci a yanar gizo. Hukumomi sun yi kuka da kyarkeci a 2005 da 2009 tare da mura kuma ga abin da kuke samu yanzu," ya rubuta. A ranar 20 ga Maris, Tom ya buga na ƙarshe BMJ post akan hikimar babban kanti. A cikin Oktoba 2020, Carl ya tsaya a matsayin BMJ Babban editan EBM.
To, me ya canza?
A lokacin bazara, Tom ya ƙaddamar da bita na Cochrane akan ayyukan da ba na magunguna ba ga BMJ bisa buƙatar ɗaya daga cikin masu gyara. An buga sabuntawar bita guda biyu da suka gabata a cikin BMJ (2008 da 2009) don amsa cutar ta murar alade, kuma akwai buƙatar sabuntawa. Bita - wanda aka sabunta ta ƙarshe a cikin 2011 - ya girma cikin girma kuma an ƙaddamar da shi a cikin sassa biyu - kashi na farko ya haɗa da abin rufe fuska da shaidar nesa, wanda aka ƙi bayan kwamitin a ranar 10 ga Afrilu, kuma an ƙi kashi na biyu ba tare da sake dubawa ba.
Editoci sun bayyana "damuwa" saboda tazarar amincewar ba ta ware babban tasirin kariya ga masu ba da lafiya da matsakaicin (kuma mai yuwuwar mahimmanci) ga jama'a na fuskokin fuska. Har ila yau, sun so su rage ma'aunin shaida: "Mafi yawan masu gyara sun ji cewa yana da mahimmanci a haɗa shaidar RCT tare da shaidar gani." A bayyane yake, "nazarin kula da shari'o'in, na iya zama da kyau sosai don kallon tasirin matakan kariya."
A ƙarshe, bitar ba ta sami gamsasshiyar shaida daga gwaje-gwajen da ba a tantance ba don ingancin abin rufe fuska, kariyan ido, ko nisantar mutum. Domin sakamakon bai yi daidai da tunanin editan ba, an ƙi shi.
Bambaro na ƙarshe ba shine lokacin da muka ƙaddamar da takarda akan watsawa wanda ya haifar da sharhin sake dubawa na batanci ba. Ya kasance bazawa na wani kisan gilla da ya yanke, 'Yaya mafi kyawun masana kimiyya za su iya ja da baya kan kamfen ɗin musun kimiyya?'
Marubutan Gavin Yamey da David Gorski ba su bincika labarin nasu ba, babu haƙƙin amsa ko sadarwa tare da Sunetra Gupta ko Carl, kuma BMJ tunanin yana da kyau a yi wa waɗanda aka ambata a matsayin “’yan kasuwan shakka.”
A cikin Binciken RealClear, Paul Thacker ya ruwaito, "Yayin da Gorski da Yamey ba su ba da wata shaida cewa kuɗin Koch sun tallafa wa masu rattaba hannu na GBD, BMJ har yanzu sun buga labarin su… Spectator.
Smearing na COVID-Era - da tashin matattu - na Trump NIH Nadin Dr. Jay Bhattacharya
Mun buga sau da yawa a cikin BMJ tun 1995, gami da labarai da yawa tare da babban editan (misali, 2017, 2019), kuma mun yi aiki tare a kan Yakin Tamiflu da ALLTrials kokarin. Koyaya, ƙungiyar Ioannidis ta nuna abin da kowa da kowa a cikin ilimin kimiyya zai iya ƙara gani a cikin cutar ta Covid- BMJ ba su nuna son kai, kuma sun zaɓi fifita gefe ɗaya yayin bala'in cutar ta Covid.
Mujallun likitanci suna nufin raba sabbin ilimin likitanci, gami da binciken bincike. Koyaya, tare da haɓakar intanet, sun fara haɗawa da ƙarin labarai, ra'ayoyi, da labaran da suka fi dacewa da tsarin mujallu.
Jaridun da ke nuna rashin son kai da rashin nuna son kai yayin annoba sun kasa wakiltar shaidar da ake da su daidai. Duk da haka, sanannun sanannun suna ba su damar yin tasiri sosai, yana ba su damar tsara ra'ayoyin likitoci, yin tasiri ga maganganun ilimi, da kuma taka muhimmiyar rawa wajen tsara manufofin jama'a. Wannan na iya haifar da karɓar ra'ayi mai ban sha'awa, a ƙarshe yana tasiri ga yanke shawara na kiwon lafiya da martani ga rikice-rikicen lafiya.
Budaddiyar tattaunawa da binciko ra'ayoyi daban-daban suna da mahimmanci don yanke shawara mai fa'ida, mai tasiri. The review na Covid-19 ba da ra'ayin nuna son kai a cikin BMJ Ya ƙarasa da cewa, 'BMJ ta lalata ikon kewaya rikitattun al'amurran da suka shafi annoba da muka fuskanta kuma sun zaɓi yin ra'ayi akan shaida.' Ta hanyar kawar da tattaunawa mai mahimmanci,
Da zarar tushen tushe na tushen shaida, da BMJ jarida bata hanya. Tarihi zai yanke hukunci cewa rashin muhawara ya kasance sanannen kuskure.
An sake bugawa daga marubucin Mayarwa
-
Carl Heneghan darekta ne na Cibiyar Nazarin Shaida ta Magunguna da GP. Masanin ilimin cututtuka na asibiti, yana nazarin marasa lafiya da ke samun kulawa daga likitocin, musamman ma wadanda ke da matsalolin gama gari, tare da manufar inganta tushen shaidar da ake amfani da su a aikin asibiti.
Duba dukkan posts
-
Tom Jefferson babban mai koyarwa ne a Jami'ar Oxford, tsohon mai bincike a Cibiyar Nordic Cochrane kuma tsohon mai kula da kimiyya don samar da rahotannin HTA game da marasa magunguna na Agenas, Hukumar Kula da Lafiya ta Yanki ta Italiya.
Duba dukkan posts
